Health and Human Services Secretary Robert F. Kennedy Jr. plans to meet Tuesday with executives of companies that make infant formula, people familiar with the matter told Bloomberg’s Rachel Cohrs Zhang, Madison Muller, Anna Edney and Kelsey Butler. It is not clear exactly which companies will be represented, though companies that sell infant formula in the U.S. include Abbott Laboratories (ABT), which makes Similac, and Enfamil maker Reckitt Benckiser (RBGLY), said the report, which noted that Kennedy plans to discuss nutritional standards and shoring up the supply chain.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Insulet expands Omnipod 5 to four more International markets
- Abbott’s Whitfield case re-trial granted, not overturned, says BofA
- Positive Long-Term Outlook for Abbott Laboratories Despite Short-Term NEC Litigation Risks
- Citi sees overturned verdict in state case as incrementally negative for Abbott
- Abbott put volume heavy and directionally bearish
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue